awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34056295-1B139685-3C39-4087-944F-241649BBE5AD
Q34056295-1B139685-3C39-4087-944F-241649BBE5AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34056295-1B139685-3C39-4087-944F-241649BBE5AD
Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee
P2860
Q34056295-1B139685-3C39-4087-944F-241649BBE5AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34056295-1B139685-3C39-4087-944F-241649BBE5AD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b547ff175135d1fbcb1297177b86f4ad66ddff8
P2860
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib.